IFN-γ-dependent delay of in vivo tumor progression by Fas overexpression on murine renal cancer cells

Journal of Immunology

Volumn 164, Issue 1, 2000, Pages 231-239

  Lee, Jong Keuk ^a   Sayers, Thomas J ^b   Brooks, Alan D ^b   Back, Timothy C ^b   Young, Howard A ^a   Komschlies, Kristin L ^b   Wigginton, Jon M ^c   Wiltrout, Robert H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; MONOCLONAL ANTIBODY; RECOMBINANT GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL KILLING; CONTROLLED STUDY; GENE OVEREXPRESSION; KIDNEY CARCINOMA; LYMPHOCYTIC INFILTRATION; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR; SURVIVAL TIME; T LYMPHOCYTE SUBPOPULATION; TUMOR REGRESSION;

EID: 0033985454     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.1.231     Document Type: Article

References (32)

1. Nagata, S. Apoptosis by death factor. 1997. Cell 88:355.
2. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449.
3. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16:39.
4. Cohen, P. L., and R. A. Eisenberg. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243.
5. Adachi, M., S. Suematsu, T. Kondo, J. Ogasawara, T. Tanaka, N. Yoshida, and S. Nagata. 1995. Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat. Genet. 11:294.
6. Giorfano, C., G. Stassi, R. D. Maria, M. Todaro, P. Richiusa, G. Papoff, G. Ruberti, M. Bagnasco, R. Testi, A. Galluzzo. 1997. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275: 960.
7. Ogasawara, J., F. R. Watanabe, M. Adachi, A. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata. Lethal effect of the anti-Fas antibody in mice. Nature 364:806.
8. Watanabe-Fukunaga, R., C. I. Brannan, N. Itoh, S. Yonehara, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148:1274.
9. Weller, M., K. Frei, P. Groscurth, P. H. Kran, Y. Yon, and A. Fontana. 1994. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells: induction and modulation of sensitivity by cytokines. J. Clin. Invest. 94:954.
10. Fellenberg, J., H. Mau, C. Scheuerpflug, V. Ewerbeck, and K.-M. Debatin. 1997. Modulation of resistance to anti-APO-1-induced apoptosis in osteosarcoma cells by cytokines. Int. J. Cancer 72:536.
11. Suda, T., T. Okazaki, Y. Naito, T. Yokota, N. Arai, S. Ozaki, K. Nakao, and S. Nagata. 1995. Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154:3806.
12. Ferguson, T. A., and T. S. Griffith. A vision of cell death: insights into immune privilege. Immunol. Rev. 156:167.
13. Walker, P. R., P. Saas, and P.-Y. Dietrich. 1997. Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back. J. Immunol. 158:4521.
14. O'Connell, J., G. C. O'Sullivan, J. K. Collins, and F. Shanahan. 1996. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J. Exp. Med. 184:1075.
15. Zeytun, A., M. Hassuneh, M. Nagarkatti, and P. S. Nagarkatti. 1997. Fas-Fas ligand-based interactions between tumor cells and tumor-specific cytotoxic T lymphocytes: a lethal two-way street. Blood 90:1952.
16. Trauth, B. C., C. Klas, A. M. J. Peters, S. Matzku, P. Moller, W. Falk, K.-M. Debatin, P. H. Krammer. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301.
17. Yoshida, Y., N. Anzai, H. Kawabata. 1996. Apoptosis in normal and neoplastic hematopoiesis. Crit. Rev. Oncol. Hemetol. 24:185.
18. Westendorf, J. J., J. M. Lammert, and D. F. Jelinek. 1995. Expression and function of Fas (APO-1/CD95) in patient myeloma cells and myeloma cell lines. Blood 85:3566.
19. Dirks, W., S. Schone, C. Uphoff, H. Quentmeier, S. Pradella, and H. G. Drexler. 1997. Expression and function of CD95 (Fas/APO-1) in leukaemia-lymphoma tumor lines. J. Haematol. 96:584.
20. Karawajew, L., C. Wuchter, V. Ruppert, H. Drexler, H.-J. Gruss, B. Dorken, and W.-D. Ludwig. 1997. Differential CD95 expression and function in T and B lineage acute lymphoblastic leukemia cells. Leukemia 11:1245.
21. Wigginton, J. M., K. L. Komschlies, T. C. Back, J. L. Franco, M. J. Brunda, and R. H. Wiltrout. 1996. Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma. J. Natl. Cancer Inst. 88:38.
22. 111Indium-oxine. J. Immunol. Methods 43:319.
23. Sayers, T. J., A. D. Brooks, J.-K. Lee, R. G. Fenton, K. L. Komschlies, J. M. Wigginton, R. Winkler-Pickett, and R. H. Wiltrout. 1998. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contribution of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells. J. Immunol. 161:3957.
24. Kaplan, D. H., V. Shankaran, A. S. Dighe, E. Stockert, M. Aguet, L. J. Old, and R. D. Schreiber. 1998. Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. USA 95:7556.
25. Thompson, C. B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456.
26. Kimura, K., K. Asami, and M. Yamamoto. 1997. Structure of the promoter for the rat Fas antigen gene. Biochim. Biophys. Acta 1352:238.
27. Rubin, B. Y., L. J. Smith, G. R. Hellermann, R. M. Lunn, N. K. Richardson, S. L. Anderson. 1988. Correlation between the anticellular and DNA fragmenting activities of tumor necrosis factor. Cancer Res. 48:6006.
28. Arai, H., D. Gordon, E. G. Nabel, and G. J. Nabel. 1997. Gene transfer of Fas ligand induces tumor regression in vivo. Proc. Natl. Acad. Sci. USA 94:13862.
29. Xu, X., X.-Y. Fu, J. Plate, and A. S.-F. Chong. 1998. IFN-γ induces cell growth inhibition by Fas-mediated apoptosis: requirement of STATI protein for up-regulation of Fas and FasL expression. Cancer Res. 58:2832.
30. + T cell activation and IFN-γ production. J Immunol. 161:2848.
31. Bartholeyns, J., and M. Lopez. 1994. Immune control of neoplasia by adoptive transfer of macrophages: potentiality for antigen presentation and gene transfer. Anticancer Res. 14:2673.
32. Horton, M. R., C. M. McKee, C. Bao, F. Liao, J. M. Farber, J. Hodge-DuFour, E. Pure, B. L. Oliver, T. M. Wright, and P.W. Noble. 1998. Hyaluronan fragments synergize with interferon-γ to induce the C-X-C chemokines Mig and interferon-inducible protein-10 in mouse macrophages. J. Biol. Chem. 273:35088.